Kindstar Globalgene Technology, Inc.

Kindstar Globalgene Technology, Inc.

HHKEX:9960
0.89
HKD
+0.00
(-0.56%)
926.33MMarket Cap
Mar 26Next Earn

Total Valuation

HKD

As of June 30, 2026, Kindstar Globalgene Technology, Inc. carries a market capitalization of 926.33M, placing it among publicly traded companies globally. Its enterprise value stands at -553.43M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap926.33M
Enterprise Value-553.43M

Important Dates

Kindstar Globalgene Technology, Inc.'s next confirmed earnings release is scheduled for March 26, 2027.

Earnings Date3/26/2027

Share Statistics

As of June 30, 2026, Kindstar Globalgene Technology, Inc. has 996.05M shares outstanding.

Shares Outstanding996.05M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio0.31
P/TBV Ratio0.34

Financial Position

As of June 30, 2026, Kindstar Globalgene Technology, Inc. maintains a current ratio of 2.84, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.

Current Ratio2.84
Quick Ratio2.16
Debt / Equity14.96

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count3,100.00

Stock Price Statistics

HKD

As of the close on November 17, 2026, Kindstar Globalgene Technology, Inc.'s stock has declined approximately 30.47% over the past 52 weeks. The 50-day moving average sits at 0.91, while the 200-day moving average is 1.03.

52-Week Price Change-30.47%
50-Day Moving Average0.91
200-Day Moving Average1.03

Balance Sheet

HKD

As of June 30, 2026, Kindstar Globalgene Technology, Inc. holds 2.01B in cash and equivalents against 456.50M in total debt, resulting in a net debt position of -292.24M. Total book value stands at 2.98B, with working capital of 1.71B providing operational flexibility.

Cash & Cash Equivalents2.01B
Total Debt456.50M
Net Debt-292.24M
Equity (Book Value)2.98B
Book Value Per Share2.99
Working Capital1.71B